ReceptoPharm, Inc. was incorporated as Receptogen in the United States under the laws of the State of Nevada on June 4, 2001 for the purpose, among other things, of developing and acquiring patents based upon advanced receptor and molecular biology. The name was changed to ReceptoPharm in April of 2003 and the company was licensed to do business in the State of Florida.

Company was acquired by Nutra Pharma Corp.